GovWire

COVID-19 vaccines and medicines: updates for November 2022

Medicines Healthcare Products Regulatory Agency

November 29
14:00 2022

Summaries of Yellow Card reporting

We continue to publish the summaries of the Yellow Card reporting for the COVID-19 vaccines being used in the UK. The report summarises information received via the Yellow Card scheme and includes other data such as usage of COVID-19 vaccines and relevant epidemiological data. The report is updated regularly to include other safety investigations carried out by the MHRA under the?COVID-19 Vaccine Surveillance Strategy.

Other recent MHRA updates on Coronavirus vaccines and medicines:

We have also recently:

See guidance on COVID-19 for all our latest information, including after publication of this article.We previously included summaries of latest COVID-19 information, including in the July 2022, August 2022, September 2022 and October 2022 issues of Drug Safety Update.

Reporting Yellow Cards

Report suspected side effects to medicines, vaccines and medical device and test kit incidents used in coronavirus (COVID-19) testing and treatment using:

For products under additional monitoring (?) such as the COVID-19 vaccines, you should report all suspected adverse side effects. This will allow the MHRA to identify new safety information for these products.

When reporting please provide as much information as possible, including information about medical history, any concomitant medications, onset timing, and treatment dates, and for vaccines, the product brand name and batch number.

You may be contacted following submission of a Yellow Card report so that we can gather additional relevant information for the assessment of the report. These contributions form an important part of our understanding of suspected side effects.

If you have been forwarded this article, subscribe directly to Drug Safety Update via our website.

Article citation: Drug Safety Update volume 16, issue 4: November 2022: 3.?

Published 29 November 2022

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: